COMMUNIQUÉS West-GlobeNewswire

Myriad Genetics to Present at the 37th Annual J.P. Morgan Healthcare Conference
27/12/2018
SALT LAKE CITY, Dec. 27, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN) announced today that Mark C. Capone, president and CEO, Myriad Genetics, is scheduled to present at the 37 th annual J.P. Morgan [...]
Blood donors encouraged to keep appointments to help patients this holiday season
27/12/2018
OTTAWA, Dec. 27, 2018 (GLOBE NEWSWIRE) -- Canadian Blood Services is asking donors to keep their appointments to give blood during the holidays to help ensure blood and blood products are available for those in need. On [...]
La Société canadienne du sang encourage les donneurs à respecter leur rendez-vous
27/12/2018
OTTAWA, 27 déc. 2018 (GLOBE NEWSWIRE) -- La Société canadienne du sang demande aux donneurs qui ont un rendez-vous pendant la période des Fêtes de respecter leur engagement. Il est important que les donneurs se [...]
G1 Therapeutics to Present at 37th Annual J.P. Morgan Healthcare Conference
27/12/2018
RESEARCH TRIANGLE PARK, N.C., Dec. 27, 2018 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today announced that Chief Executive Officer Mark Velleca, M.D., Ph.D., will [...]
Cyclacel Pharmaceuticals to Present at Biotech Showcase™ 2019 in San Francisco
27/12/2018
BERKELEY HEIGHTS, N.J., Dec. 27, 2018 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC, Nasdaq:CYCCP) ("Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on [...]
Axsome Therapeutics Provides Year End 2018 Clinical Update
27/12/2018
FDA clearance of IND received for Phase 2 trial of AXS-12 in narcolepsy Phase 2 results of AXS-05 in major depressive disorder on track for early January 2019 Phase 3 results of AXS-05 in treatment resistant depression [...]
Osmotica Pharmaceuticals Appoints Seasoned Financial Executive Gregory Cowan to Board of Directors and Audit Committee
27/12/2018
BRIDGEWATER, N.J., Dec. 27, 2018 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (“Osmotica” or the “Company”) (Nasdaq: OSMT), a fully integrated biopharmaceutical company, today announced that Gregory Cowan, a [...]
HEXO reaches construction and licensing milestones for its massive 1 million sq. ft. greenhouse – on time and on budget
27/12/2018
GATINEAU, Quebec, Dec. 27, 2018 (GLOBE NEWSWIRE) -- HEXO Corp (“HEXO” or the “Company”) (TSX: HEXO ) has reached a construction and licensing milestone with the first phase of its 1 million sq. ft. greenhouse expansion [...]
HEXO atteint des jalons concernant sa serre d’un million de pieds carrés – construction et octroi de licence – selon les délais et le budget prévus
27/12/2018
GATINEAU, Québec, 27 déc. 2018 (GLOBE NEWSWIRE) -- HEXO Corp (« HEXO » ou la « Société ») (TSX: HEXO ) a franchi une étape importante touchant la première phase de l’agrandissement d’un million de pieds carrés de sa [...]
Transactions in relation to share buyback program
27/12/2018
Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 2, 2018, in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]
Organic electronics: Bio-on presents Eloxel, to develop the use of bioplastics in the electronics sector. At his side Kartell, strategic partner
27/12/2018
ELOXEL is born ( organic electronics for electronics ) the new company created by Bio-on to exploit the patents destined to revolutionize the world of electronics through the use of bioplastics. The aim is to enable [...]
Financial calendar of JSC Olainfarm for 2019
27/12/2018
JSC Olainfarm informs that in 2019 submission of financial results is scheduled for the following dates: Unaudited consolidated Annual Report for 2018 – on February 28, 2019; Unaudited consolidated interim financial [...]
Rule 2.9 Announcement
27/12/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 27 December 2018 [...]
TRACON Pharmaceuticals Presents Positive Top-line Clinical Data from Dose Escalation Portion of Phase 1 Trial of TRC105 and Opdivo® for Treatment of Non-Small Cell Lung Cancer
26/12/2018
SAN DIEGO, Dec. 26, 2018 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, [...]
IntelGenx Grants Restricted Share Units
26/12/2018
SAINT LAURENT, Quebec, Dec. 26, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. ("IntelGenx", or the “Company”) (TSX-V: IGX) (OTC.QX:IGXT) announced today that the Company’s board of directors granted Restricted [...]
Sanofi: FDA Approves VAXELIS(TM), Sanofi and MSD's Pediatric Hexavalent Combination Vaccine
26/12/2018
FDA Approves VAXELIS (TM) , Sanofi and MSD's Pediatric Hexavalent Combination Vaccine PARIS and KENILWORTH, N.J. - December 26 , 2018 - The U.S. Food and Drug Administration has approved VAXELIS(TM) (Diphtheria and [...]
Sanofi : La FDA approuve VAXELIS(TM), le vaccin combiné hexavalent pédiatrique de Sanofi et MSD
26/12/2018
La FDA approuve VAXELIS (TM) , le vaccin combiné hexavalent pédiatrique de Sanofi et MSD PARIS et KENILWORTH (New Jersey) - Le 26 décembre 2018 - La Food and Drug Administration (FDA) des États-Unis a approuvé VAXELIS( [...]
Alzamend Neuro™ Completes New Management Team for 2019
26/12/2018
Appoints Financial Executive, Kenneth S. Cragun, as New CFO and Treasurer Tampa, Fla., Dec. 26, 2018 (GLOBE NEWSWIRE) -- Alzamend Neuro™, Inc. (Alzamend™ or the “Company”) announced today that it has appointed top-tier [...]
TRACON Pharmaceuticals Announces Submission of IND Application for TJ4309 (CD73 Antibody TJD5) for Treatment of Advanced Solid Tumors
26/12/2018
SAN DIEGO, Dec. 26, 2018 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, [...]

Pages